» Articles » PMID: 32320469

Risk Factors for Skin, Mucosal, and Organ Bleeding in Adults with Primary ITP: a Nationwide Study in Japan

Overview
Journal Blood Adv
Specialty Hematology
Date 2020 Apr 23
PMID 32320469
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Bleeding manifestations in primary immune thrombocytopenia (ITP) range from skin petechiae to life-threatening intracranial hemorrhage (ICH). However, the relation between these various bleeding manifestations and the platelet count in ITP remains poorly characterized. Using a nationwide database of patients with ITP during the years 2005 to 2014 (10 years) in Japan, we analyzed 19 415 adult patients newly diagnosed with ITP, including 222 with ICH. The frequency of skin purpura was 64.8%, and this increased linearly with thrombocytopenia without a specific platelet count threshold. In contrast, mucosal bleeding (epistaxis and gingival bleeding) and organ bleeding (melena, hematuria, and ICH) increased exponentially with thrombocytopenia at a platelet count threshold of 10 to 15 × 109/L. Age showed a much weaker correlation than platelet count with skin and mucosal bleeding. However, the incidence of organ bleeding increased exponentially above 60 years of age. Multivariate analysis showed that the presence of mucosal bleeding was a risk factor for occurrence of melena and hematuria but not for ICH. The frequency of ICH was 1.1% and risk factors for ICH were age ≥60 years (odds ratio [OR], 3.09; 95% confidence interval [CI], 2.13-4.47; P < .001), platelet count <10 × 109/L (OR, 2.96; 95% CI, 2.11-4.15; P < .001), and the presence of hematuria (OR, 1.56; 95% CI, 1.04-2.35; P = .033). The relation between ICH and platelet count varied with age. This large-scale analysis of risk factors for bleeding in ITP has revealed distinct characteristics of skin, mucosal, and organ bleeding in adult patients with newly diagnosed ITP, thus indicating those who are at a high risk of severe organ bleeding.

Citing Articles

Impact of platelet transfusion and bleeding risk stratification in patients with immune thrombocytopenia before procedures.

Kang K, Choi Y, Lim H, Kwak K, Choi Y, Park Y Sci Rep. 2025; 15(1):5174.

PMID: 39939729 PMC: 11822007. DOI: 10.1038/s41598-025-89419-w.


Analysis of Risk Factors and the Establishment of a Predictive Model for Thrombosis in Patients with Immune Thrombocytopenia.

Liang H, Duan L, Long M, Tie S, Sun C, Ma S Clin Appl Thromb Hemost. 2025; 31():10760296241301398.

PMID: 39763222 PMC: 11705361. DOI: 10.1177/10760296241301398.


Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia.

Schifferli A, Le Gavrian G, Aladjidi N, Moulis G, Godeau B, Leblanc T Blood Adv. 2024; 8(24):6183-6194.

PMID: 39374586 PMC: 11696666. DOI: 10.1182/bloodadvances.2024014381.


Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.

Kashiwagi H, Kuwana M, Murata M, Shimada N, Takafuta T, Yamanouchi J Int J Hematol. 2023; 119(1):1-13.

PMID: 37957517 PMC: 10770234. DOI: 10.1007/s12185-023-03672-1.


How we treat primary immune thrombocytopenia in adults.

Liu X, Hou Y, Hou M J Hematol Oncol. 2023; 16(1):4.

PMID: 36658588 PMC: 9850343. DOI: 10.1186/s13045-023-01401-z.


References
1.
Arnold D . Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2015; 2015:237-42. DOI: 10.1182/asheducation-2015.1.237. View

2.
Rodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel J . Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood. 2013; 121(14):2596-606. DOI: 10.1182/blood-2012-07-442392. View

3.
Melboucy-Belkhir S, Khellaf M, Augier A, Boubaya M, Levy V, Le Guenno G . Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 cases. Am J Hematol. 2016; 91(12):E499-E501. DOI: 10.1002/ajh.24529. View

4.
Buchanan G, Adix L . Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr. 2002; 141(5):683-8. DOI: 10.1067/mpd.2002.128547. View

5.
Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T . High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood. 1991; 77(1):31-3. View